DP13

· Damian Pharma AG

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for DP13, covering 2018-04-17 to 2024-11-22. Get the full timeline:

Most recent: Clinical Trial Update: DP13 - A Phase II Study in Patients With Primary Aldosteronism [Phase 2]